New Radioisotope for Cancer Therapy – A new Collaboration to produce Copper-67

SASKATOON, SK, Aug. 25, 2021 /CNW/ – Iotron Medical Inc. (Iotron) and Canadian Isotope Innovations Corp. (CIIC) are pleased to announce a collaboration to produce the radioisotope copper-67 (Cu-67) for new cancer therapies. This investment will increase the production capacity of the CIIC-operated facilities in Saskatoon, making Cu-67 more widely available to international cancer researchers. (read more)